Cargando…
Split dosing of coronavirus disease 2019 vaccines provides noninferior antibody responsiveness to conventional vaccine dosing
Autores principales: | Musa, Amal, Wood, Macy, Rorie, Andrew, May, Sara M., Graaff, Joel Van De, Poole, Jill A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448634/ https://www.ncbi.nlm.nih.gov/pubmed/36084864 http://dx.doi.org/10.1016/j.anai.2022.08.995 |
Ejemplares similares
-
SPLIT-DOSING OF COVID-19 VACCINES IS SAFE AND PROVIDES NON-INFERIOR ANTIBODY RESPONSIVENESS TO CONVENTIONAL VACCINE DOSING
por: Musa, A., et al.
Publicado: (2022) -
Split-dosing of coronavirus disease 2019 vaccines
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing?
por: Greenhawt, Matthew
Publicado: (2022) -
NACI greenlights second doses, dose splitting of monkeypox vaccine
por: Vogel, Lauren
Publicado: (2022) -
Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women
por: Hu, Yue-Mei, et al.
Publicado: (2019)